Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Vaccine Effectiveness × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 520 Neoplasms 399 Carcinoma, Non-Small-Cell Lung 307 Colorectal Neoplasms 284 Lung Neoplasms 233 Prostatic Neoplasms 211 Carcinoma, Hepatocellular 204 Stomach Neoplasms 157 Pancreatic Neoplasms 142 Multiple Myeloma 131 Leukemia, Myeloid, Acute 128 Uterine Cervical Neoplasms 126 Recurrence 114 Rectal Neoplasms 114 Squamous Cell Carcinoma of Head and Neck 102 Ovarian Neoplasms 102 Neoplasm Metastasis 98 Head and Neck Neoplasms 86 Esophageal Neoplasms 84 Triple Negative Breast Neoplasms 83 Glioblastoma 83 Endometrial Neoplasms 79 Brain Neoplasms 79 Small Cell Lung Carcinoma 78 Colonic Neoplasms 77 Melanoma 69 Precursor Cell Lymphoblastic Leukemia-Lymphoma 68 Glioma 65 Hematologic Neoplasms 64 Motor Activity 63

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡